Added sugar, total sugar and fructose from some sources were all linked to a higher risk for coronary heart disease, according to the results of research published in the American Journal of Clinical Nutrition. Kristine K. Dennis, PhD, MPH, a nutrition scientist and data analyst at Emory University, and colleagues wrote that, although increased total sugar intake has been associated with

Compared with placebo, injectable semaglutide 2.4 mg reduced risk for major adverse CV events by 20% for people with overweight or obesity and established CVD, according to topline data from the SELECT study.The data are the first to demonstrate a reduction in hard CV outcomes for a drug approved for chronic weight management in a large, randomized controlled trial.